ShrutiGuptaMDMPH

Acute Renal Failure

Director of Onco-Nephrology Research, BWH/DFCI

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2016 - 2019
Massachusetts General HospitalResidency, Internal Medicine, 2013 - 2016
University of Virginia School of MedicineClass of 2013, MD, Alpha Omega Alpha

PubMed

855 citations
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
Hanny Al-Samkari, Rebecca Karp Leaf, Walter H. Dzik, Jonathan C. T. Carlson, Annemarie E. Fogerty
Blood. 2020-07-23
327 citations
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.
Shruti Gupta, Wei Wang, Salim S. Hayek, Lili Chan, Kusum S. Mathews
JAMA Internal Medicine. 2021-01-01
46 citations
Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020.
Shruti Gupta, Frank B Cortazar, Leonardo V Riella, David E Leaf
Kidney360. 2020-02-27

Journal Articles

Type 2 Diabetes and the Risk of Incident Hearing Loss
Shruti Gupta, Gary C Curhan, Diabetologia

Research Spotlight: Radiology Test Can Be Used to Diagnose Immune Checkpoint Inhibitor-Associated Acute Kidney InjurySeptember 5th, 2024
Analysis Questions Tocilizumab in Ventilated COVID PatientsMarch 3rd, 2022
Predictors of AKI Related to Immune Checkpoint Inhibitor Use IdentifiedNovember 7th, 2021
Join now to see all